Contact
Please use this form to send email to PR contact of this press release:
Theravance Biopharma Submits Investigational New Drug (IND) Application for TD-0714, an Inhibitor of Neprilysin (NEP)
TO:
Please use this form to send email to PR contact of this press release:
Theravance Biopharma Submits Investigational New Drug (IND) Application for TD-0714, an Inhibitor of Neprilysin (NEP)
TO: